ILMN Illumina Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ILMN

Price (delayed)

$383.94

Market cap

$56.06B

P/E Ratio

89.08

Dividend/share

N/A

EPS

$4.31

Enterprise value

$54.45B

Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.illumina.com

Illumina, Inc. is an American company. Incorporated in April 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a ...

Highlights

The quick ratio has grown by 28% from the previous quarter and by 12% YoY
The equity has increased by 6% YoY and by 4.9% from the previous quarter
Illumina's revenue has increased by 7% QoQ but it has decreased by 2.3% YoY
The company's gross profit rose by 7% QoQ but it fell by 6% YoY
The stock's price to earnings (P/E) is 59% more than its 5-year quarterly average of 56.0 and 12% more than its last 4 quarters average of 79.4
Illumina's debt has surged by 53% YoY and by 52% QoQ

Key stats

What are the main financial stats of ILMN
Market
Shares outstanding
146M
Market cap
$56.06B
Enterprise value
$54.45B
Valuations
Price to earnings (P/E)
89.08
Price to book (P/B)
11.38
Price to sales (P/S)
16.14
EV/EBIT
60.16
EV/EBITDA
49.68
EV/Sales
15.68
Earnings
Revenue
$3.47B
EBIT
$905M
EBITDA
$1.1B
Free cash flow
$890M
Per share
EPS
$4.31
Free cash flow per share
$6.1
Book value per share
$33.74
Revenue per share
$23.79
TBVPS
$52.9
Balance sheet
Total assets
$8.76B
Total liabilities
$3.83B
Debt
$2.82B
Equity
$4.92B
Working capital
$4.37B
Liquidity
Debt to equity
0.57
Current ratio
4.45
Quick ratio
4.06
Net debt/EBITDA
-1.47
Margins
EBITDA margin
31.6%
Gross margin
67.6%
Net margin
18.1%
Operating margin
16.8%
Efficiency
Return on assets
8.1%
Return on equity
13.3%
Return on invested capital
17.5%
Return on capital employed
12.1%
Return on sales
26.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ILMN stock price

How has the Illumina stock price performed over time
Intraday
1.82%
1 week
-2.27%
1 month
-4.15%
1 year
22.52%
YTD
3.77%
QTD
-0.03%

Financial performance

How have Illumina's revenue and profit performed over time
Revenue
$3.47B
Gross profit
$2.35B
Operating income
$584M
Net income
$630M
Gross margin
67.6%
Net margin
18.1%
The operating income has decreased by 40% YoY
Illumina's operating margin has decreased by 38% YoY and by 6% from the previous quarter
ILMN's net income is down by 33% year-on-year and by 4% since the previous quarter
Illumina's net margin has decreased by 32% YoY and by 11% QoQ

Growth

What is Illumina's growth rate over time

Valuation

What is Illumina stock price valuation
P/E
89.08
P/B
11.38
P/S
16.14
EV/EBIT
60.16
EV/EBITDA
49.68
EV/Sales
15.68
The stock's price to earnings (P/E) is 59% more than its 5-year quarterly average of 56.0 and 12% more than its last 4 quarters average of 79.4
Illumina's EPS has decreased by 33% YoY and by 3.8% QoQ
The equity has increased by 6% YoY and by 4.9% from the previous quarter
The price to book (P/B) is 3.5% higher than the 5-year quarterly average of 11.0 and 3.5% higher than the last 4 quarters average of 11.0
ILMN's P/S is 26% above its 5-year quarterly average of 12.8 and 3.5% above its last 4 quarters average of 15.6
Illumina's revenue has increased by 7% QoQ but it has decreased by 2.3% YoY

Efficiency

How efficient is Illumina business performance
The company's return on assets fell by 39% YoY and by 9% QoQ
The ROE has contracted by 36% YoY and by 6% from the previous quarter
Illumina's return on sales has decreased by 17% YoY and by 6% QoQ
ILMN's return on invested capital is down by 16% year-on-year

Dividends

What is ILMN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ILMN.

Financial health

How did Illumina financials performed over time
The total assets is 128% more than the total liabilities
Illumina's total liabilities has increased by 46% YoY and by 33% from the previous quarter
The quick ratio has grown by 28% from the previous quarter and by 12% YoY
Illumina's debt is 43% lower than its equity
Illumina's debt has surged by 53% YoY and by 52% QoQ
The debt to equity is up by 43% since the previous quarter and by 43% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.